BIOMAT Database Logo BIOMAT Database Logo

Receptors for insulin and insulin-like growth factors in disease. 1980

M M Rechler, and E E Schilling, and G S King, and F Fraioli, and A M Rosenberg, and O Z Higa, and J M Podskalny, and C Grunfeld, and P Nissley, and C R Kahn

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D004392 Dwarfism A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height. Nanism
D006133 Growth Substances Signal molecules that are involved in the control of cell growth and differentiation. Mitogens, Endogenous,Endogenous Mitogens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M M Rechler, and E E Schilling, and G S King, and F Fraioli, and A M Rosenberg, and O Z Higa, and J M Podskalny, and C Grunfeld, and P Nissley, and C R Kahn
Receptors for insulin-like growth factors.
January 1989, Journal of internal medicine,
M M Rechler, and E E Schilling, and G S King, and F Fraioli, and A M Rosenberg, and O Z Higa, and J M Podskalny, and C Grunfeld, and P Nissley, and C R Kahn
Insulin-like growth factors and their receptors in growth.
September 1996, Endocrinology and metabolism clinics of North America,
M M Rechler, and E E Schilling, and G S King, and F Fraioli, and A M Rosenberg, and O Z Higa, and J M Podskalny, and C Grunfeld, and P Nissley, and C R Kahn
[Insulin-like growth factors and their receptors].
January 1990, Duodecim; laaketieteellinen aikakauskirja,
M M Rechler, and E E Schilling, and G S King, and F Fraioli, and A M Rosenberg, and O Z Higa, and J M Podskalny, and C Grunfeld, and P Nissley, and C R Kahn
Multifunctional glycoprotein receptors for insulin and the insulin-like growth factors.
January 1989, Ciba Foundation symposium,
M M Rechler, and E E Schilling, and G S King, and F Fraioli, and A M Rosenberg, and O Z Higa, and J M Podskalny, and C Grunfeld, and P Nissley, and C R Kahn
Receptors for the insulin-like growth factors on human erythrocytes.
August 1983, The Journal of clinical endocrinology and metabolism,
M M Rechler, and E E Schilling, and G S King, and F Fraioli, and A M Rosenberg, and O Z Higa, and J M Podskalny, and C Grunfeld, and P Nissley, and C R Kahn
Insulin-like growth factors: Ligands, binding proteins, and receptors.
October 2021, Molecular metabolism,
M M Rechler, and E E Schilling, and G S King, and F Fraioli, and A M Rosenberg, and O Z Higa, and J M Podskalny, and C Grunfeld, and P Nissley, and C R Kahn
Characterization of receptors for insulin-like growth factors in human brain.
January 1991, Gerontology,
M M Rechler, and E E Schilling, and G S King, and F Fraioli, and A M Rosenberg, and O Z Higa, and J M Podskalny, and C Grunfeld, and P Nissley, and C R Kahn
Insulin-like growth factors and their receptors in muscle development.
January 1991, Advances in experimental medicine and biology,
M M Rechler, and E E Schilling, and G S King, and F Fraioli, and A M Rosenberg, and O Z Higa, and J M Podskalny, and C Grunfeld, and P Nissley, and C R Kahn
Insulin-like growth factors and kidney disease.
February 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation,
M M Rechler, and E E Schilling, and G S King, and F Fraioli, and A M Rosenberg, and O Z Higa, and J M Podskalny, and C Grunfeld, and P Nissley, and C R Kahn
Structural and functional homologies in the receptors for insulin and the insulin-like growth factors.
November 1982, Cell,
Copied contents to your clipboard!